FDA Investigator Rachel C Harrington

Rachel C Harrington has conducted inspections on 93 sites in 8 countries as of 29 Jan 2018. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
93
Last Inspection Date:
29 Jan 2018
Investigator Role:
FDA Investigator
Redica ID:
100003848
Countries of Inspections:
United States of America, Denmark, China, Japan, Germany, Korea (Republic of), Belgium, India
FDA Investigators that have inspected at least one site in common with Rachel C Harrington:
Alan P Kurtzberg, Alberto A Viciedo, Alice S Tsao, Alison N Stieg, Amy Devlin, PhD, Anastasia G Lolas, Andrea L Williams Jones, Andrea Siegel, PhD, Andrew J Howard, Andrew O Ejiofor, Anitha Palamakula Govada, Anjali Shukla, PhD, Ankur C Patel, Annet R Rajan, Anthony F Lorenzo, Anthony J Donato, Anthony W Hite, Anthony W Lee, Ashley L Reiber, Austin B Appler, Azeezat M Lawal, Barbara A Gullick, Barbara J Holladay, Barbara Janine Breithaupt, Bijoy Panicker, Bo Chi, PhD, Bobbie L Whiddon, Bonita S Chester, Brian M Janelsins, PhD, Brian M Palermo, Brian R Yaun, Brooke K Higgins, Brooke K Seeman, Bruce C Kovak, Burnell M Henry, Byungja E Marciante, Candice C Mandera, Candice J Cortes, Carl Lee, Carol L Rehkopf, Carole L Jones, Cassandra K Johnson, Catherine O Lamptey, CDR Ileana Barreto Pettit, Chaltu Nwakijra, Charles R Bonapace, PhD, Cheryl A Clausen, Chiang Syin, PhD, Chilton L Ng, Christian D Lynch (CDL), Christina K Theodorou, Christine M Whitby, CSO, Clarice J Ahn, Colleen F Hoyt, Craig D Zagata, Cynthia A Harris, MD, RN, Cynthia Jim, CSO, Dana D Carter, SR DDS, Daniel R Azar, David A Oluwo, David L Chon, David M Beltran, David P Rice, Jr, Deborah J Parris, Debra Bower, Debra I Love, Dell S Moller, Denise M Digiulio, Dennis Cantellops Paite, Derek S Smith, PhD, Dessa A Antoine, Deyaa Shaheen, Dhaval H Patel, Diane T Bargo, Diane T O'brien, Doan T Nguyen, PharmD, Don H Bark, PhD, Donald C Obenhuber, PhD, Douglas A Campbell, Dr. Dominick Roselle, Dr. Gang Wang, PhD, Dr. Mark J Seaton, PhD, Dr. Roslyn F Powers, Dr. Sriram Subramaniam, PhD, Dr. Yubing Tang, Dr. Zhihao Qiu (Peter), PhD, Dr. Zhou Chen (nmi), MD PhD, Dung N Tran, Edette J Newby, Edmund F Mrak, Jr, Edward P Potter, Edwin Melendez, Elvis D Morton, Emest F Bizjak, Emily Leongini, Emmanuel A Dimaano, Jr, Ephrem Hunde, PhD, Eric L Dong, BS, Erik T Nagaoka, Erin L Mcfiren, Esaw, Evan Tong, Felix Maldonado, Frances Namuswe, PhD, Frederick F Razzaghi, Gale L Glinecki, Gavin T Cua, George Pyramides, Gerald B Seaborn, Jr, German Rivera, Haijing Hu, Hector Jcolon Torres, Henry K Lau, Holly S Simms, Hongna Wang, Ivis L Negron, Jacqueline Johnson, Jacqueline Mdiaz Albertini, Jai P Singh, Jaison J Eapen, James K Rice, James M Mason, James M Simpson, James Norman, James P Mcreavey, James W Leonette, Jamie D Richardson, Jamie D Swann, Jane M Kreis, Janet A Rajan, Jee Chung, PhD, Jeffrey A Reed, Jennifer Lalama, Jennifer Swisher, PhD, Jesse P Hardin, Jessica Hankins, PhD, Jessica K Yoon, Jessica L Pressley, Jessica S Estriplet, Joel D Hustedt, Joey C West, Jogy George, John Dan, Johnny D Nwankwo, Johnson, Jonah S Ufferfilge, Jonathan W Chapman, Jorge L Guadalupe, José E Meléndez, Jose M Cayuela, Jose R Hernandez, Joseph W Matthews, Joshua S Hunt, Julie A Silberberg, Julie D Bringger, Junho Pak, Justin A Boyd, Justin A Hefferman, Jyoti B Patel, PhD, Kalavati Suvarna, PhD, Karen A Coleman, Karen A Spencer, Katherine M Williams, Kathleen M Jordan, Kathy Lee, Keith M Reilly, Kelly L Anderson, Kenneth M Gordon, Kenneth Nieves, Kevin P Regan, Kham Phommachanh, Kim Lthomas Cruse, Ko U Min, Krista N Flores, Kristina J Donohue, Kristina L Conroy, Kurt A Brorson, PhD, Lakisha M Williams, Latoya S Oliver Powell, Lauren N Barber, Laurissa S Flowers, Lawrence Harmon, Jr, Lawrence J Stringer, LCDR Anastasia M Piliafas Brown, LCDR Cornelius Brown, III, LCDR Debra Emerson, LCDR Susan E Polifko, Leonard H Lavi, Liatte Kreuger, PharmD, Linda F Murphy, Lisa M Bellows, Lori S Lawless, Lorraine L Chavis, LT Luis O Rodriguez, LT Richard A Lyght, Lucas B Leake, Luis A Dasta, Lynette P Salisbury, Madushini Dharmasena, PhD, Malgorzata G Norton, PhD, Marc A Jackson, Jr, Marc S Neubauer, Marcellinus D Dordunoo, Marcia D Fields, Marcus A Ray, Margaret M Doherty, Maria Gutierrez Lugo, PhD, Marie F Morin, Marion Michaelis, Mary E Farbman, PhD, Matthew B Casale, Matthew M Henciak, Megan A Haggerty, Melissa J Garcia, Merideth K Rose, Michael A Charles, Michael A Taylor, Michael F Skelly, PhD, Michael J Vardon, Michael L Casner, Michael O Idowu, Michael Shanks, MS, Mihaly S Ligmond, Mildred L Mccray, Mindy M Chou, Mohamad A Chahine, Monique Rac Lester, Mra B Kamberem, Mujadala M Abdul Majid, Myra L Gemmill, Myra L Reed, Nadeem I Chaudhry, Nancy G Schmidt, Natasha A Dezinna, Natasha Gupta, Nawab A Siddiqui, Nebil A Oumer, Nelson N Ayangho, Nerizza B Guerin, Nicholas A Violand, Nicole K Trudel, Nina D Patel, Norman K Starks, Olaide Akinmade, Olumide A Akinyemi, Osama M Hamoud, Pamela N Agaba, Paraluman S Leonin, Parul M Patel, Patricia A Morrow, Patrick C Klotzbuecher, Patsy J Domingo, Paul E Stein, Paul L Bellamy, Peter E Baker, Philip J Snoy, Prabhu P Raju, Pratik S Upadhyay, DDC, Puspa Suresh Jayasekara, Qin Xu, Quyen T Tran, Rachael O Oyewole, Raymond T Oji, Rebecca Rodriguez, Regina Gibson Melton, Regina T Brown, Richard Heath Coats, Richard Ledwidge (nmi), PhD, Robert H Wittorf, Robert J Maffei, Robert J Martin, Robert L Hummel, Robin Levis, PhD, Ronald T Nowalk, Rose Ashley, Roseline N Boateng, Russell J Glapion, Samina S Khan, Sarah M Shannon, Satheesh Thomas, Scott R Nichols, PhD, Scott T Ballard, Scott T Panagiotis, Sena G Dissmeyer, Shadia Zaman, PhD, Sharon K Thoma, PharmD, Shirshendu K Deb, PhD, Shusheen A Alexander, Simone E Pitts, Sixto M Mercado Rios, Stacey A Priest, Stacie A Woods, Stephanie L Shapley, Steven C Madzo, Steven E Bowen, PhD, Steven J Thurber, Steven M Weinman, Steven P Donald, Susan M Jackson, Susan T Hadman, Suzanne M Healy, Suzanne M Muchene, Swati Verma, Tajah L Blackburn, Tamal K Chakraborti, PhD, Tamara N Champion, Tania E Garcia, Tania E Vizcaino, Tarun D Mehta, Teegan Dellibovi Ragheb, PhD, Tekalign Wondimu, Temar Q Williams, Thai D Truong, Theresa M Smedley, Thomas E Friel, Thomas J Arista, Thomas N Adjabeng, Thomas R Withers, Thuy T Nguyen, LCDR, Tiffani D Wilson, Todd M Stankewicz, Tonia F Bernard, Toyin B Oladimeji, Truong Xuan Nguyen (Andy), Uduak M Inokon, Unnee Ranjan, Upendra Paudel, Valerie G Vallely, Vipulchandra N Dholakia, Virgilio F Pacio, CSO, Viviana Matta, Vivin George, Walter L Fava, Wanda Y Fields, Wanda Y Honeyblue, Wayne L Jefferson, Wendy G Tan, PhD, William A Warnick, William C Macfarland, William H Linkroum, William J Leonard, Xiandong Meng, Xiaoping Guan, Xiaoshi N Wang, Yaharn Su, Yan Qin, Yasamin Ameri, Young M Yoon, Yumi J Hiramine, Yvins Dezan, Zachary L Miller, Zhongren Wu, Zi Qiang Gu

Rachel C Harrington's Documents

Publish Date Document Type Title
June, 2014 FDA 483 Response UPM Pharmaceuticals - Form 483R, 2014-06-19
December, 2013 EIR Eisai Inc. - EIR, 2013-12-17
June, 2010 FDA 483 NOXELL CORPORATION - Form 483, 2010-06-02
December, 2012 FDA 483 RX South DBA RX3 Compounding Pharmacy LLC - Form 483, 2012-12-14
September, 2011 FDA 483 Charles River Laboratories Germany GmbH - Form 483, 2011-09-23
April, 2012 FDA 483 Jubilant Cadista Pharmaceuticals, Inc. - Form 483, 2012-04-05
September, 2010 FDA 483 Response SriSai Biopharmaceutical Solutions, LLC - Form 483R, 2010-10-06
August, 2012 FDA 483 Cangene BioPharma, LLC - Form 483, 2012-08-01
August, 2012 FDA 483 SOFIE Co. dba SOFIE - Form 483, 2012-08-16
March, 2013 FDA 483 American Antibiotics,Inc. - Form 483, 2013-03-28
March, 2013 FDA 483 FVS Holdings, Inc. dba. Green Valley Drugs - Form 483, 2013-03-15
July, 2012 FDA 483 BioReliance Corporation - Form 483, 2012-07-03
October, 2012 EIR Pharmaceutics International, Inc. - EIR, 2012-10-22
March, 2012 FDA 483 Cardinal Health 414, LLC - Form 483, 2012-03-20
May, 2011 FDA 483 Merck Sharp & Dohme LLC - Form 483, 2011-05-12
April, 2010 FDA 483 Bell-More Labs Inc - Form 483, 2010-04-09
February, 2011 FDA 483 Izeen Pharma Inc - Form 483, 2011-02-25
January, 2013 FDA 483 Tishcon Corporation - Form 483, 2013-01-30
July, 2009 FDA 483 Pharmaceutics International, Inc. - Form 483, 2009-07-29
August, 2012 EIR Cangene BioPharma, LLC - EIR, 2012-08-01
March, 2013 EIR American Antibiotics,Inc. - EIR, 2013-03-28
December, 2013 FDA 483 Eisai Inc. - Form 483, 2013-12-17
September, 2010 FDA 483 SriSai Biopharmaceutical Solutions, LLC - Form 483, 2010-09-24
May, 2012 FDA 483 Konsyl Pharmaceuticals, Inc. - Form 483, 2012-05-31
January, 2013 EIR Tishcon Corporation - EIR, 2013-01-30
April, 2009 FDA 483 Alberto R. Yataco, M.D. - Form 483, 2009-04-06
November, 2011 FDA 483 Chempacific Corporation - Form 483, 2011-11-18
May, 2013 EIR Pharmaceutics International, Inc. - EIR, 2013-05-22
May, 2013 FDA 483 Pharmaceutics International, Inc. - Form 483, 2013-05-22
September, 2010 EIR SriSai Biopharmaceutical Solutions, LLC - EIR, 2010-09-24
April, 2013 FDA 483 Bell-More Labs Inc - Form 483, 2013-04-26
December, 2010 FDA 483 Shire Pharmaceuticals, Inc. - Form 483, 2010-12-02
November, 2012 FDA 483 UPM Pharmaceuticals - Form 483, 2012-11-13
March, 2015 FDA 483 Bell-More Labs Inc - Form 483, 2015-03-13
July, 2014 FDA 483 Actavis Mid Atlantic LLC - Form 483, 2014-07-25
April, 2009 EIR Alberto R. Yataco, M.D. - EIR, 2009-04-06
December, 2014 FDA 483 PharmaLogic CSP, Inc. - Form 483, 2014-12-12
September, 2013 EIR Merck Sharp & Dohme LLC - EIR, 2013-09-30
January, 2011 FDA 483 Bell-More Labs Inc - Form 483, 2011-01-26
February, 2018 FDA 483 Hanlim Pharm. Co., Ltd. - Form 483, 2018-02-06
November, 2015 FDA 483 WES PHARMA INC - Form 483, 2015-11-06
October, 2009 FDA 483 Izeen Pharma Inc - Form 483, 2009-10-22
March, 2009 FDA 483 Woodhaven Pharmacy Services, LLC dba Remedi SeniorCare - Form 483, 2009-03-19
October, 2012 FDA 483 Pharmaceutics International, Inc. - Form 483, 2012-10-22
August, 2013 FDA 483 Lincare Inc - Form 483, 2013-08-09
April, 2009 FDA 483 Response Alberto R. Yataco, M.D. - Form 483R, 2009-04-10
August, 2012 EIR SOFIE Co. dba SOFIE - EIR, 2012-08-16
September, 2013 FDA 483 Merck Sharp & Dohme LLC - Form 483, 2013-09-30
July, 2011 FDA 483 Cangene BioPharma, LLC - Form 483, 2011-07-22
May, 2015 FDA 483 Wockhardt Limited - Form 483, 2015-05-26
January, 2013 FDA 483 Johns Hopkins University, The - Form 483, 2013-01-10

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more